Seroquel (quetiapine) does have anticholinergic activity, though the story is more nuanced than a simple yes or no. The drug itself has weak binding to muscarinic receptors, but once your body metabolizes it, the resulting compound is a potent muscarinic blocker. On the Anticholinergic Cognitive Burden (ACB) scale, quetiapine receives a score of 3, the highest possible rating, placing it among the most anticholinergically active medications in clinical use.
How Quetiapine Produces Anticholinergic Effects
What makes quetiapine unusual is that the parent drug and its main metabolite behave very differently. Quetiapine itself has low affinity for muscarinic M1 receptors, with an equilibrium dissociation constant of 1,400 nM, a relatively weak binding strength. If that were the whole picture, quetiapine would barely register as an anticholinergic.
The key player is norquetiapine, the active metabolite your liver produces when it breaks down the drug. Norquetiapine has high affinity for muscarinic M1 receptors, and this is what drives the anticholinergic side effects people experience. M1 receptors are concentrated in the brain and gut, so blocking them affects cognition, saliva production, digestion, and bladder function.
How It Compares to Other Antipsychotics
Among second-generation antipsychotics, quetiapine falls in the middle of the anticholinergic spectrum. Clozapine sits at the top, with anticholinergic activity measured at 27 to 250 pmol/mL of atropine equivalents at therapeutic doses. Olanzapine comes next at 1 to 15 pmol/mL. Quetiapine registers at 0 to 5.4 pmol/mL, notably lower than both but still clinically relevant.
On the other end, risperidone, aripiprazole, and ziprasidone show no measurable anticholinergic activity at any concentration studied. So if you’re comparing options, there’s a clear dividing line: clozapine, olanzapine, and quetiapine carry anticholinergic burden, while the others essentially do not. All three show dose-dependent increases, meaning higher doses produce stronger anticholinergic effects.
Side Effects Linked to Anticholinergic Activity
The classic anticholinergic side effects show up in quetiapine clinical trials at measurable rates. In short-term studies of people with schizophrenia, constipation occurred in 9% of those taking quetiapine compared to 5% on placebo, and dry mouth affected 7% versus 2% on placebo. Blurred vision is classified as common, occurring in 1% to 10% of users. Urinary retention is less frequent, reported in under 1% of patients.
These side effects tend to be more noticeable at higher doses used for schizophrenia and bipolar disorder (300 to 800 mg daily) than at the lower doses sometimes prescribed off-label for sleep (25 to 100 mg). That said, even at lower doses, norquetiapine is still being produced, so some degree of anticholinergic effect is possible.
Why the ACB Score of 3 Matters
The Anticholinergic Cognitive Burden scale, developed by researchers at the Regenstrief Institute, rates medications from 1 (mildly anticholinergic) to 3 (definitely anticholinergic with known cognitive effects). Quetiapine’s score of 3 means it’s considered a definite anticholinergic with potential to affect thinking, memory, and attention, particularly in older adults.
This rating becomes especially important when you’re taking multiple medications. Anticholinergic burden is cumulative. If you’re already on another drug with a score of 2 or 3, such as certain antihistamines, bladder medications, or tricyclic antidepressants, adding quetiapine stacks the total burden higher. A combined ACB score of 3 or more is associated with increased risk of confusion, falls, and cognitive decline in older populations.
For younger adults, the cognitive effects are typically milder and often limited to dry mouth and constipation that many people tolerate without major disruption. But the anticholinergic load is still worth tracking, especially if side effects like brain fog, difficulty concentrating, or memory lapses develop after starting the medication or increasing the dose.
Practical Considerations
If you’re experiencing anticholinergic side effects from quetiapine, there are a few things worth knowing. These effects are dose-dependent, so they tend to improve if the dose is reduced. They can also be more pronounced in the first few weeks and may partially settle as your body adjusts. Staying hydrated and increasing dietary fiber can help manage dry mouth and constipation, the two most common complaints.
If you’re concerned about anticholinergic burden, especially if you take several medications, a pharmacist can calculate your total ACB score. This gives you a clearer picture than looking at any single drug in isolation. For people who need an antipsychotic but want to minimize anticholinergic exposure, risperidone, aripiprazole, and ziprasidone are alternatives that don’t carry this particular burden, though they come with their own distinct side effect profiles.